Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
CoronaVac Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021 4 1
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 9 0
FN3A Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
FN3C Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
FN3D Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
Excel (.xslx) CSV (.csv)